SpyGlass Pharma, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SpyGlass Pharma, Inc. (SGP) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.71 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- SpyGlass Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 4.71M shares, a 78.98% decline year-over-year.
- SpyGlass Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 4.63M shares, a 71.27% decline year-over-year.
- SpyGlass Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 22.42M shares.
- SpyGlass Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 16.10M shares.
- SpyGlass Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 23.75M shares, a 113.48% increase from fiscal 2024.
- SpyGlass Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 11.12M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|
| 2026-06-30 | 4.71M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 4.63M shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 23.75M shares 10-K · filed 2026-03-26 | |
| 2025-06-30 | 22.42M shares 10-Q · filed 2026-08-06 | |
| 2025-03-31 | 16.10M shares 10-Q · filed 2026-05-14 | |
| 2024-12-31 | 11.12M shares 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |